Glarakis I S, Savva S, Spandidos D A
Laboratory of Virology, Medical School, University of Crete, Heraklion, Crete, Greece.
Oncol Rep. 1998 Nov-Dec;5(6):1451-4. doi: 10.3892/or.5.6.1451.
The activation of ras genes has been established as one of the steps in the process of colon tumorigenesis. These genes are converted into active oncogenes by point mutations in codons 12, 13, and 61, although a more complex way has also been shown, through alteration of gene expression. In order to investigate the spectrum of ras gene mutations, we examined 78 colorectal polypoid adenomas and 76 primary colorectal adenocarcinomas for codon 12 point mutations in K-, H- and N-ras, using a PCR-RFLP assay. K-ras mutations were found in 42.3% (33/78) of adenomas and in 36.8% (28/76) of carcinomas. Statistically significant association (p=0.043) was found between the frequency of K-ras mutations in mixed adenomas larger than 2 cm, compared to smaller mixed adenomas. On the other hand, adenocarcinomas harbored more frequently mutations, when indicating development from adenoma (p=0.016), in higher grade of differentiation (p=0.001) and in females with tumor located proximal to the rectosigmoid (p=0.013). No mutations were found in H-ras. The incidence of N-ras mutations was 1.3% in adenomas and adenocarcinomas (1/78 and 1/76 respectively). Based on our results, we propose the possibility that K-ras-dependent tumor development results in the formation of less aggressive neoplasms, than the process of K-ras-independent carcinogenesis. Our findings and other previous reports indicate that K-ras mutations might be a secondary stress-effect from extrinsic or intrinsic stimulatory factors and that these mutations are not necessarily involved in the malignant transformation of the cell.
ras基因的激活已被确认为结肠肿瘤发生过程中的步骤之一。这些基因通过密码子12、13和61的点突变转化为活性癌基因,不过也有研究表明存在一种更复杂的方式,即通过基因表达的改变来实现。为了研究ras基因突变谱,我们采用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP分析),检测了78例结直肠息肉样腺瘤和76例原发性结直肠癌中K-、H-和N-ras基因密码子12的点突变情况。在腺瘤中,K-ras突变的发生率为42.3%(33/78),在癌中为36.8%(28/76)。与较小的混合性腺瘤相比,大于2cm的混合性腺瘤中K-ras突变频率存在统计学显著关联(p = 0.043)。另一方面,当腺癌显示由腺瘤发展而来时(p = 0.016)、分化程度较高时(p = 0.001)以及肿瘤位于直肠乙状结肠近端的女性患者中(p = 0.013),腺癌更频繁地出现突变。未发现H-ras基因突变。腺瘤和腺癌中N-ras基因突变的发生率均为1.3%(分别为1/78和1/76)。基于我们的研究结果,我们提出一种可能性,即与不依赖K-ras的致癌过程相比,依赖K-ras的肿瘤发展会导致形成侵袭性较低的肿瘤。我们的研究结果以及其他先前的报告表明,K-ras突变可能是外在或内在刺激因素产生的继发性应激效应,并且这些突变不一定参与细胞的恶性转化。